Acute endothelial cell apoptosis and microvascular compromise couple gastrointestinal tract irradiation to reproductive death of intestinal crypt stem cell clonogens (SCCs) following high-dose radiation. Genetic or pharmacologic inhibition of endothelial apoptosis prevents intestinal damage, but as the radiation dose is escalated, SCCs become directly susceptible to an alternate cell death mechanism, mediated via ceramide synthase (CS)-stimulated de novo synthesis of the proapoptotic sphingolipid ceramide, and p53-independent apoptosis of crypt SCCs. We previously reported that ataxia-telangiectasia mutated deficiency resets the primary radiation lethal pathway, allowing CS-mediated apoptosis at the low-dose range of radiation. The mechanism for this event, termed target reordering, remains unknown. Here, we show that inactivation of DNA damage repair pathways signals CS-mediated apoptosis in crypt SCCs, presumably via persistent unrepaired DNA double-strand breaks (DSBs). Genetic loss of function of sensors and transducers of DNA DSB repair confers the CS-mediated lethal pathway in intestines of sv129/B6Mre11 ATLD1/ATLD1 and C57BL/ 6 Prkdc/SCID (severe combined immunodeficient) mice exposed to low-dose radiation. In contrast, CS-mediated SCC lethality was mitigated in irradiated gain-of-function Rad50 s/s mice, and epistasis studies order Rad50 upstream of Mre11. These studies suggest unrepaired DNA DSBs as causative in target reordering in intestinal SCCs. As such, we provide an in vivo model of DNA damage repair that is standardized, can be exploited to understand allele-specific regulation in intact tissue, and is pharmacologically tractable. Cancer
Introduction
Permanent damage to intestinal mucosa requires depletion of the crypt stem cells and early undifferentiated progenitors [termed here stem cell clonogens (SCCs)], located at positions 6 to 9 from the bottom of the crypt of Lieberkühn (1, 2) . When exposed to 8 to 16 Gy whole-body radiation (WBR), intestinal SCC lethality occurs via reproductive cell death (2) , linked to and regulated by an early wave of acid sphingomyelinase (ASMase)-dependent endothelial apoptosis and ensuing dysfunction of the crypt microvascular network (3, 4) . Reproductive cell death is generic to irradiated mammalian cells, resulting from unrepaired or misrepaired DNA double-strand breaks (DSBs), which confer genomic instability and postreplication generation of mutations and chromosomal aberrations, eventually leading to death of injured progeny (5) .
DNA damage initiates a coordinated signaling network that senses exposed DSBs, arrests cell cycle progression, and either activates DSB repair via nonhomologous end joining (NHEJ) or homologous recombination (HR; ref. 6) or signals cell death (7) . Regulation of pathway choice is unknown, nor is there evidence that the DNA damage signaling network distinguishes between reparable and irreparable DSBs. Evidence suggests that, in the early phase, repair is preferentially expressed (7), whereas DSB persistence, when cellular repair capacity is exceeded or dysregulated, eventually confers cell death. Consistent with this latter notion, although HR is significantly enhanced when NHEJ is suppressed pharmacologically or genetically (8) , NHEJ-deficient cells are nonetheless radiation hypersensitive (9, 10) , resulting from residual unrepaired DSBs, as HR incompletely complements NHEJ deficiency.
Although DSB-mediated reproductive cell death is primary in radiation lethality in crypt SCCs, some tissues use apoptosis in pathogenesis of tissue damage. The most heralded apoptotic death pathway signaled by IR-induced DSBs is mediated via p53, which in Caenorhabditis elegans germ cells involves the sphingolipid ceramide during the mitochondrial phase of the apoptotic cascade (11) . Ceramide is metabolically produced either via sphingomyelinase-mediated hydrolysis of sphingomyelin or via ceramide synthase (CS)-mediated de novo synthesis (12, 13) . In irradiated C. elegans germ cells, radiation activates simultaneously the ceramide synthetic pathway via CS and independently the CEP-1/p53-EGL-1 (BH3-only protein) pathway via DNA damage-activated cell cycle checkpoint genes (11, 14) . These pathways converge on mitochondrial membranes, where a rise in ambient ceramide regulates EGL-1-mediated displacement of CED-4 (homologue of Apaf-1) from the CED-4:CED-9 (Bcl-2 homologue) complex, effecting cytosolic CED-3 caspase activation and apoptosis (11) . The mitochondrial response in C. elegans germ cells is equivalent to induction of mitochondrial outer membrane permeabilization and cytochrome c release in mammalian systems, which irreversibly commits cells to the final effector phase of apoptosis.
CS engagement in mammalian apoptosis is cell type specific in response to ionizing radiation (IR), drugs, and cytokines (15) (16) (17) (18) . An extensive literature has accumulated about signaling of apoptotic cell death through CS. As opposed to ceramide generation at the plasma membrane via ASMase, signaling through CS is delayed in almost every system defined to date. For example, ceramide generation and CS activity in bovine aortic endothelial cells (BAEC) exposed to 5 Gy were observed beginning at 8 hours and peaking at 16 hours after exposure (17) , whereas daunorubicin-induced ceramide generation and CS activity were observed beginning at 6 hours and peaking at 8 hours after exposure in P388 murine leukemia cells (15) . Studies using metabolic incorporation of 125 I-labeled 5-iodo-2′-deoxyuridine ([ 125 I]dURd) into DNA of endothelial cells provided evidence that damage confined to DNA may signal posttranscriptional CS activation. 125 I decays by electron capture, emitting cascades of low-energy Auger electrons, which when incorporated into DNA deposit their total radiation energy within <40 Å, producing DSBs within 6 bp of the site of incorporation (19) (20) (21) . In BAECs, [ 125 I] dURd-mediated apoptosis induced posttranscriptional activation of CS, de novo ceramide synthesis, and apoptosis, inhibitable by a natural specific competitive CS inhibitor, fumonisin B 1 (FB1; ref. 17) . The biological significance of CS as transducer of apoptosis has been confirmed in vivo, as CS transactivates disease pathogenesis in gastric ulcer, ischemiareperfusion, and emphysema rodent models of human disease (1, (22) (23) (24) (25) (26) . In these reports, epithelial apoptosis occurred 18 to 24 hours after radiation exposure, or about 6 to 10 hours after CS activation, and was inhibited by FB1.
In previous studies, we showed that although acute, ASMase-dependent, endothelial apoptosis and ensuing microvascular dysfunction couple gastrointestinal tract irradiation to reproductive death of crypt SCCs following 8 to 16 Gy, dose escalation to ≥17 Gy results in switching the target for radiation gastrointestinal lethality to CS-mediated apoptosis directly within crypt SCCs (1) . Unlike the C. elegans germ cell response, this CS-mediated apoptosis is p53 independent (1). Notably, ataxia-telangiectasia mutated (ATM) deficiency resets lethality, allowing CS-mediated apoptosis to initiate crypt SCC lethality at the low-dose radiation range. Accordingly, ATM deficiency hypersensitizes mice to the radiation gastrointestinal syndrome, shifting the ED 50 from 16.5 Gy to 4.5 Gy (3.7-fold; P < 0.05), preempting microvascularmediated damage (1) . The mechanism for this change in the crypt SCC lethal pathway in ATM-deficient mice, termed target reordering (1), remains unknown.
The present studies address the mechanism of target reordering from the coupled endothelial apoptosis/reproductive death pathway to CS-mediated lethality of irradiated crypt SCCs. Whereas ATM is a core kinase transducer of signals generated by Mre11 complex sensing of DSBs in the HR pathway (27) , we tested the hypothesis that signals, generated by genetic manipulation of various sensors/transducers of DSB repair, affect DSB-induced CS activation. We used the irradiated gastrointestinal model in mice carrying loss-or gainof-function mutations (lf and gf, respectively) in the Mre11 complex, which consists of Mre11, Rad50, and NBS1 (27) . The lf Mre11 ATLD1/ATLD1 mice harbor a Mre11 COOH-terminally truncated mutation and exhibit reduced DNA DSB repair and IR hypersensitivity (27, 28) , whereas gf Rad50 s/s mice encode a hypermorphic variant of Rad50 and express constitutive ATM kinase activity (29, 30) . We also studied C57BL/6
Prkdc/SCID severe combined immunodeficient (SCID) mice, which carry a germ-line lf mutation in DNA-dependent protein kinase (DNA-PK), a transducing kinase of the NHEJ DNA repair pathway (9, 31, 32) . We find a generic relationship between inactivation of DNA damage repair genes and CS-mediated apoptotic death of crypt SCCs. Furthermore, CS-mediated SCC lethality was mitigated in irradiated gf Rad50 s/s mice, and epistasis studies ordered Rad50 upstream of Mre11. These studies thus suggest that unrepaired DNA DSBs are causative in target reordering in intestinal SCCs.
Materials and Methods
Mice. C57BL/6, ATM knockout (129s6/SvEvTac-Atm tm1awb/j), and SCID (in C57BL/6 background) male mice, 8 to 12 wk old, were purchased from The Jackson Laboratory.
Mre11
ATLD1/ATLD1 , Chk2 −/− , and Rad50 s/s hypermorphic mice (in sv129 C57BL/6 background) were propagated using heterozygous breeding pairs provided by the laboratory of John Petrini (Memorial Sloan-Kettering Cancer Center, New York, NY) and genotyped as described (29, 33, 34) . Mice were housed at the animal core facility of Memorial Sloan-Kettering Cancer Center. This facility is approved by the American Association for Accreditation of Laboratory Animal Care and is maintained in accordance with the regulations and standards of the U.S. Department of Agriculture and the Department of Health and Human Services, NIH. Protocols for conducting animal experiments were approved by the Memorial Sloan-Kettering Cancer Center Research Animal Resource Center.
Irradiation, delivery of basic fibroblast growth factor and FB1, bone marrow transplantation, and tissue preparation. WBR was delivered with a Shepherd Mark-I unit (model 68, SN643) operating 137 Cs sources. The dose rate was 2.35 Gy/min. Human recombinant basic fibroblast growth factor (bFGF) from SCIOS was delivered i.v. by retro-orbital injection as described (35) . FB1 from BIOMOL was solubilized in normal saline and injected i.p. (25 mg/g mouse body weight) 30 min before WBR. To obtain tissue specimens, mice were sacrificed by hypercapnia asphyxiation and 2.5-cm segments of proximal jejunum (2 cm distal to the ligament of Trietz), as well as the head and proximal femur, were obtained. Intestinal and bone specimens were fixed by overnight incubation in 4% neutral buffered formaldehyde. Fixed tissues were embedded in paraffin blocks and sections of full organ circumference (5 μm thick) were obtained by microtomy, adhered to polylysine-treated slides, and deparaffinized by heating at 90°C for 10 min and at 60°C for 5 min, washed twice in xylene for 5 min each, and stained with H&E. Bone marrow cells were prepared, and bone marrow transplantation (BMT) was carried out according to a standard protocol, as described (4) .
Survival of mice after WBR and autopsy evaluation of animal death. Actuarial survival was calculated by the product-limit Kaplan-Meier method (36) , and statistical significance of differences in survival was calculated by the Mantel log-rank test (37) . Causes of death were evaluated in autopsy specimens and classified as described (4) .
Measurement of tissue levels of ceramide and CS activity. Tissue CS activity was measured in microsomal membranes prepared from scraped mucosa specimens. Scraped mucosa was washed with cold PBS, pelleted, and resuspended in 4 mL homogenization buffer [25 mmol/L HEPES (pH 7.4), 5 mmol/L EGTA, 50 mmol/L NaF, and 10 μg/mL each of leupeptin and soybean trypsin inhibitor]. Cells were then disrupted, microsomal membrane was obtained, and ceramide levels and CS activity were measured in freshly prepared microsomal membranes as described (1) .
Quantitation of crypt clonogen apoptosis. Intestinal tissue specimens were obtained 4 to 24 h after WBR, fixed in 4% fresh formaldehyde, and embedded in paraffin, and 5-μm sections were evaluated for apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL), as described (4). The apoptotic index was scored as published (4) in full longitudinal sections of crypts containing 10 or more adjacent epithelial cells, at least 1 Paneth cell, and a lumen. Frequency of apoptosis for each cell position from the crypt bottom was scored in 200 half crypt sections and reported as mean ± SE.
Quantitation of intestinal microvascular endothelial apoptosis. Intestinal tissue specimens were obtained at 4 h after WBR, fixed in 4% fresh formaldehyde, and embedded in paraffin, and 5-μm sections were evaluated for endothelial apoptosis by TUNEL-CD34 double staining as described (4) .
Crypt microcolony assays. Crypts were identified histologically according to established criteria (4) . Surviving crypts were defined as containing 10 or more adjacent chromophilic non-Paneth cells, at least 1 Paneth cell, and a lumen. The number of surviving crypts was counted in the whole circumference of the transverse cross-section of the intestine. We scored nine circumferences per mouse and used four to five mice to generate each data point. Data are reported as mean ± SE.
Results
Mre11-deficient and SCID mice exposed to WBR are hypersensitive to lethality from the gastrointestinal syndrome. We first defined baseline radiosensitivity parameters of mice harboring lf mutations of DNA repair enzymes. Table  1 shows that Mre11 ATLD1/ATLD1 mice displayed severe hypersensitivity to WBR, associated with shortened mean survival (4.8 and 4.0 days after 10 and 12 Gy, respectively) compared with wild-type littermates (10.5 and 10.2 days after 10 and 12 Gy, respectively; P < 0.01 for each). In contrast to wild-type mice, which die from marrow aplasia at 10 and 12 Gy, autopsies of Mre11 ATLD1/ATLD1 mice succumbing to these doses revealed complete destruction of the crypt-villus system with denudation of intestinal mucosa (Fig. 1A, middle left) . There was also progressive, although incomplete, hemorrhagic marrow destruction as the dose escalated from 8 to 12 Gy, although hematopoietic elements were still identifiable at time of death (Fig. 1A, middle right) . Furthermore, autologous BMT failed to rescue these mice ( Supplementary  Fig. S1 , left), confirming that intestinal destruction was the predominant cause of death. SCID mice were previously reported to exhibit 1.8-fold increase in intestinal radiosensitivity (9) . Here, we confirmed a hypersensitive intestinal radiation phenotype in our strain of C57BL/6
Prkdc/SCID mice that displayed mean survivals of 4.7 and 4.4 days after 8 and 10 Gy WBR, respectively (Table 1) . Autopsies revealed extensive and lethal gastrointestinal damage (Fig. 1A , bottom left; Table 1 ), similar to that described above in Mre11 ATLD1/ATLD1 mice, and autologous BMT failed to rescue these mice (Supplementary Fig. S1 , right). These data indicate that DNA repair deficiency results in radiation hypersensitive intestinal phenotypes that constitute the prime cause of animal lethality, as the WBR-treated mice could not be rescued by syngeneic marrow transplantation.
Mre11 hypomorphs and SCID mice exposed to lethal doses of WBR exhibit crypt SCC but not intestinal endothelial apoptosis. To assess the mechanism of gastrointestinal lethality in the lf mutant mice studied here, we selected 10 Gy for Mre11 ATLD1/ATLD1 mice and 8 Gy for C57BL/6
Prkdc/SCID mice, the minimum radiation doses that induce 100% lethal gastrointestinal damage in each strain, respectively. We first evaluated whether endothelial apoptosis is triggered by radiation dose levels that induce the gastrointestinal syndrome using double immunostaining with anti-CD34 and TUNEL.
Intestinal mucosa specimens from Mre11 ATLD1/ATLD1 and C57BL/6
Prkdc/SCID mice exposed to 8 to 10 Gy showed no evidence of significant gastrointestinal endothelial apoptosis at 4 hours after WBR, whereas concomitant wild-type control C57BL/6 mice exposed to their gastrointestinal lethal dose of 15 Gy (positive controls) showed extensive endothelial apoptosis (≥10 apoptotic lesions/villus lamina propria) as published (3, 4) . Similar to Mre11 ATLD1/ATLD1 and C57BL/ 6
Prkdc/SCID mice, C57BL/6 ATM−/− mice exposed to 8 Gy [negative controls (1)] did not display an apoptotic endothelial response (Fig. 1B) .
In contrast, significant apoptosis was detected at 18 hours after 8 to 10 Gy in the crypt SCC compartment of Mre11 ATLD1/ATLD1 and SCID mice (Fig. 1C and D) , doses significantly lower than 17 Gy, the threshold for activating SCC apoptosis in wild-type littermates (1) . Apoptotic SCCs were identified in the epithelial lining by brown TUNEL staining of condensed and fragmented nuclei at positions 6 to 9 above Paneth cells (Fig. 1C) . In the wild-type specimen at 8 to 10 Gy, crypt epithelial apoptosis was restricted to positions 4 to 5 (Fig. 1D), as reported (2, 3) . This apoptotic response has been defined as p53 dependent, induced by as little as 1 Gy IR, and not involved in the gastrointestinal syndrome (38) . Similar apoptotic changes were observed at positions 4 to 5 of SCID and Mre11 ATLD1/ATLD1 crypts exposed to 8 and 10 Gy, respectively. However, in addition, there was an increase in the apoptotic index at positions 6 to 9 at 18 hours, from a mean of 13 ± 3.8% in sv129 wild-type mice (Mre11 +/+ ) after 10 Gy to 31.7 ± 9.6% in Mre11 ATLD1/ATLD1 mice (P < 0.05; Fig. 1D ), and from 6.3 ± 3.8% in C57BL/6 controls after 8 Gy to 21.3 ± 5.5% in SCID mice (P < 0.05). CS activation mediates crypt SCC apoptosis in irradiated Mre11-deficient and SCID mice. Biochemical evidence for CS activation was confirmed by tissue measurements of CS enzymatic activity and ceramide levels in fresh extracts of intestinal mucosa before and at various times after WBR. In Mre11 ATLD1/ATLD1 intestinal mucosa, the V max of CS activity increased at 12 hours after 10 Gy 1.43-fold over unirradiated controls (from 172 ± 4.9 to 246 ± 23.6 pmol/min/mg protein; P < 0.01; Fig. 2A ), whereas there was no significant increase following 10 Gy in wild-type littermates (data not shown). An increase in intestinal ceramide content was also observed, which at 15 hours after 10 Gy reached a level of 145.0 ± 7.5% of unirradiated controls (P < 0.05; Fig. 2B ), absent in sv129/B6 wild-type animals. Similarly, C57BL/6
Prkdc/SCID exhibited 1.54-fold increased CS activity at 9 hours following 8 Gy WBR (P < 0.05; Fig. 2C ), unchanged in wild-type C57BL/6 littermates. Ceramide content also significantly increased within this same time frame in C57BL/6
Prkdc/SCID mice (P < 0.05; Fig. 2D ). These CS hypersensitive phenotypes of irradiated Mre11 ATLD1/ATLD1 and SCID SCCs are similar to that previously reported in atm −/− mice (1).
Whereas a recent study reported that transient transfection with DNA-PK catalytic subunit (DNA-PKcs) small interfering RNA (siRNA) sequences reduced ATM mRNA and protein levels in normal human fibroblasts (39), we questioned whether the hypersensitive CS phenotype of irradiated SCID or Mre11 ATLD1/ATLD1 intestines might be secondary to ATM deficiency. However, Western immunoblots of gastrointestinal mucosal extracts from SCID or Mre11 ATLD1/ATLD1 mice showed no reduction in ATM protein levels when compared with wild-type littermates (data not shown), indicating that crypt apoptosis in these mice was not associated with ATM deficiency.
CS-mediated lethality of crypt SCCs confers the intestinal radiation phenotype of Mre11-deficient and SCID mice. Although these data showed correlation between CS-mediated apoptosis in the SCC compartment and the gastrointestinal syndrome in Mre11 ATLD1/ATLD1 and C57BL/6
Prkdc/SCID mice, they are not evidence for a causative relationship. Hence, we explored the effect of the specific CS-competitive inhibitor FB1 on number of surviving crypts assessed by the microcolony assay. The 3.5-day microcolony assay (also termed crypt survival assay) is commonly used as a surrogate for quantitative evaluation of dose-dependent lethality of crypt SCCs after radiation (2, 40) . Previous studies showed that surviving fractions of ∼35% (40 regenerating crypts in total) correlate with 50% Figure 2 . DNA damage repair mutants are sensitized to CS-mediated ceramide generation. CS is activated (A) and ceramide is generated (B) in the gastrointestinal mucosa of sv129/B6Mre11 ATLD1/ATLD1 mice exposed to 10 Gy WBR. CS activity was measured in microsomes under Michaelis-Menten kinetics. Ceramide levels were quantified by diacyglycerol kinase assay. Data are pooled from triplicate determination from two experiments. Columns and points, mean; bars, SE. CS activity (C) and ceramide levels (D) determined in the gastrointestinal mucosa of Prkdc/SCID mice and wild-type C57BL/6 mice exposed to 8 Gy WBR, performed as in A and B, respectively. *, statistical significance of DNA damage mutants compared with irradiated wild-type controls at the corresponding time (P < 0.05).
of animals succumbing to the gastrointestinal syndrome (2, 40) . The dose resulting in 10% microcolony crypt survival (D 10 ) has frequently been used for interstrain comparisons of mouse sensitivity to the gastrointestinal syndrome (4, 35) . Figure 3 (Fig. 3A) show a left shift, with D 10 value decreasing from 13.0 ± 0.5 Gy in wild-type controls to 4.7 ± 0.5 Gy, yielding a dose-modifying factor (DMF) of 2.8 ± 0.1 (P < 0.005; Table 2 ). Similar sensitization was observed in Mre11 ATLD1/ATLD1 mice (Fig. 3B) , which showed a D 10 of 6.9 ± 1.2 Gy, reduced from 14.8 ± 1.3 Gy in wild-type sv129/BL6 mice (P < 0.005; DMF of 2.0 ± 0.2; Table 2 ), and in C57BL/6
Prkdc/SCID mice (Fig. 3C) , exhibiting a D 10 of 5.2 ± 0.4 Gy (P < 0.005; DMF of 2.5 ± 0.2; Table 2 ). Pretreatment with 25 mg/kg FB1, the maximal nontoxic dose in these mice, delivered 30 minutes before WBR increased the Mre11 ATLD1/ATLD1 crypt surviving fraction after 10 Gy by 3.4-fold, from 1.9 ± 0.4% observed in control FB1-untreated mice to 6.7 ± 0.6% (P < 0.001; Fig. 3D ). Similarly, FB1 pretreatment of C57BL/6
Prkdc/SCID mice before 8 Gy WBR increased crypt survival 4.0-fold, from 2.8 ± 0.4% in FB1-untreated controls to 11.0 ± 0.8% (P < 0.001; Fig. 3D ). Similar effects of FB1 on crypt survival were reported in atm −/− mice (1), permitting mucosal regeneration that was not observed in control FB1-untreated atm −/− mice.
These data support the notion that CS-mediated crypt epithelial apoptosis contributes to Mre11
and SCID SCC lethality after radiation. It should, however, be noted that in both the present and the prior atm −/− studies, FB1 provided only partial rescue of SCCs from radiation lethality. Whereas these data indicated a causative engagement of CS activation in Mre11 ATLD1/ATLD1 apoptotic crypt lethality, we explored whether Chk2 activation, a downstream element in Mre11/ATM signaling pathway of p53-mediated apoptosis (33) , is involved in CS-mediated crypt SCC apoptosis. However, Chk2 −/− mice exhibited the same SCC radiosensitivity as wild-type sv129/B6 mice (35.3 ± 1.9% versus 38.6 ± 1.6% microcolony crypt surviving fractions after 8 Gy and 1.6 ± 0.2% versus 1.5 ± 0.2% surviving fraction after 18 Gy, respectively), consistent with DSB-induced activation of the Chk2/p53 Prkdc/SCID (C) mice, assessed by the crypt microcolony assay, as described (4). D, crypt survival in sv129/B6Mre11 ATLD1/ATLD1 (12 Gy) and C57BL/6
Prkdc/SCID (10 Gy) mice with and without administration of 25 mg/kg of the CS inhibitor FB1 30 min before irradiation. Data for computation of the surviving fraction at each dose level were compiled from two to four animals irradiated concomitantly, with 9 to 20 circumferences scored per mouse. Surviving fraction per dose was calculated with the FIT software program (44) . Data were obtained from two independent experiments. Points, mean; bars, SE.
pathway as not involved in regulating CS-mediated apoptosis in crypt SCC.
The proapoptotic Rad50 s allele protects against CSmediated apoptosis and crypt lethality. Whereas genetic lf in Mre11 complex function generates a hypersensitive CS phenotype, we hypothesized that Mre11 complex gf might exhibit an opposite phenotype. The gf Rad50 S allele confers constitutive ATM kinase activity, and Rad50 s/s mice exhibit a phenotypic stress response, consisting of Chk2/ p53-mediated apoptosis of hematopoietic cells, seminiferous tubules, and intestinal crypt epithelium (41) . The hematopoietic phenotype is severe, as apoptosis leads to hematopoietic stem cell attrition and animal demise from anemia at 2 to 3 months of age, although at time of death there is no evidence of testicular or intestinal crypt attrition (29) . Figure 4A quantifies crypt apoptosis in unirradiated Rad50 s/s mice, exhibiting increased constitutive apoptosis at all crypt positions from 3 to 9, reaching a cumulative apoptotic index of 11.0 ± 2.0% compared with 2.6 ± 0.7% in wild-type controls (P < 0.05). However, when exposed to 18 Gy WBR, Rad50 s/s mice exhibited significant abrogation of SCC apoptosis at positions 6 to 9 at 18 hours after radiation. Specifically, wild-type mice exhibited a cumulative apoptotic index at positions 6 to 9 of 28.5 ± 3.2%, whereas Rad50 s/s mutants exhibited an index of 13.0 ± 4.0% (P < 0.001). The antiapoptotic effects of the Rad50 S allele in 18 Gy-irradiated crypts was matched by significant protection against crypt lethality at 3.5 days after WBR (Fig. 4B) , increasing the D 0 and D 10 values (P < 0.005; Table 2 ), translating into a protective DMF value of 1.3 ± 0.1. Although animal survival after 18 Gy WBR was not prolonged in Rad50 s/s mice ( Fig. 4C ; Table 1 ), autopsies revealed extensive and significant increase of crypt regeneration and mucosal repair in Rad50 s/s as compared with wild-type mice (data not shown; Table 1 ), with mice succumbing to severe marrow aplasia and incomplete repair of intestinal damage. Pretreatment with bFGF, which attenuates the endothelial component of radiation-induced gastrointestinal damage (3), significantly prolonged survival of Rad50 s/s mutant, but not wild-type mice, to 7.7 days (P < 0.005; Fig. 4C ), with mice succumbing to bone marrow aplasia (Table 1) while exhibiting near-complete intestinal mucosa recovery (data not shown; Table 1 ). Taken together, these data indicate that the Rad50 S allele abrogates crypt SCC apoptosis and crypt lethality, normally observed in wild-type littermates.
Because genetic mutations in two elements of the Mre11 complex, Mre11 ATLD1 and Rad50 s alleles, conferred opposing intestinal crypt apoptotic phenotypes on irradiation, we carried out epistasis studies using the 3.5-day microcolony assay as a readout. Figure 4D shows 
Discussion
The major finding of the present studies is that genetic manipulation of sensors and transducers of DNA damage repair affects gastrointestinal tract sensitivity via DSB-induced CS-mediated apoptosis of crypt SCCs. At doses lethal to the gastrointestinal tract in Mre11 ATLD1/ATLD1 and SCID mice, up to half of the log cell kill is CS dependent based on the level of FB1 protection of crypts in the microcolony assay. It should be noted that we found different lethal dose ranges for these strains. As the Mre11 ATLD1 allele is hypomorphic, whereas the Prkdc/SCID and atm −/− mice harbor null alleles, these differences cannot be construed to indicate differential contribution of these genes in conferring radiation sensitivity. This CS-mediated apoptotic response is Chk2/p53 independent. Other modes of the SCC death response are apparently nonapoptotic and may be, at least in part, regulated by Chk2/p53 signaling, consistent with previous reports that p53 inactivation is radiosensitizing to the gastrointestinal tract in the absence of enhanced apoptosis (42), apparently involving classic reproductive/clonogenic death as defined in the radiobiological literature. Although we have no data indicating that the nonapoptotic component relies on p53 inactivation, the current studies do indicate that ceramide-dependent apoptotic and ceramide-independent nonapoptotic damage to SCCs in NHEJ or HR deficiency are subject to target switching. Target switching is a recently proposed concept, which indicates that tissues operate a set of primary and secondary targets for stress-induced damage, such as occurs with IR, and that access to secondary targets is engaged when primary targets are repressed genetically or pharmacologically (1) . This concept differs from traditional concepts about tissue damage, which suggest that tissues operate one mechanism for regulating damage responsiveness/repair that is either on or s/s mice compared with wild-type littermates. Crypt apoptosis was quantified as in Fig. 1D . B, dose-response parameters of crypt survival in Rad50 s/s mice compared with wild-type littermates, as in Fig. 3 . C, actuarial survival of wild-type and Rad50 s/s mice treated with or without bFGF, performed as described in Materials and Methods. D, Mre11 signals upstream of Rad50 in radiation-induced crypt epithelial apoptosis. Wild-type sv129/B6, Mre11 ATLD1/ATLD1 , Rad50 s/s , or Mre11 ATLD1/ATLD1 /Rad50 s/s double mutants were irradiated with 8 Gy WBR. Crypt survival was quantified from two to four animals irradiated concomitantly, with 9 to 20 circumferences scored per mouse as in Fig. 3. off. In the case of the gastrointestinal tract, the primary response mechanism in a wild-type mouse engages a coordinated endothelial cell apoptosis and resultant microvascular dysfunction coupled to direct DNA damage to the SCC compartment (3, 4) . This mechanism is operative up to 16 Gy in C57BL/6 mice. On inactivating this mechanism by protecting against endothelial apoptosis, the gastrointestinal tract is protected against radiation lethality (3, 4) . However, further dose escalation restores gastrointestinal lethality as radiation switches to CS-mediated apoptosis and nonapoptotic damage to the SCC compartment to signal lethal damage (1) . This set of events seems regulated by repair/sensor enzymes and likely by persistent unrepaired DSBs and is subject to target reordering, as inactivation of ATM, Mre11, or DNA-PKcs resets CS activation as the primary response mechanism yet does not affect endothelial cell apoptosis (see Supplementary Fig. S2 ).
At present, there is no information about the transregulatory pathways initiated by DNA DSBs that lead to post-translational activation of CS. Such a pathway is, however, assumed, as we have recently found that following IR exposure of HeLa cells, CS is activated in mitochondrialassociated membrane (MAM), an ER-like structure that copurifies with mitochondria, and serves as a site for lipid synthesis and as a conduit for lipid transfer to the outer mitochondrial membrane. Consistent with MAM CS as the source of radiation-induced ceramide, our preliminary data indicate that MAM CS-generated neosynthesized ceramide is in fact transferred to outer mitochondrial membranes where it regulates BAX oligomerization. 3 MAM CS seems distinct from ER CS, which constitutively provides ceramide for trafficking to Golgi, where head groups are attached to generate the plethora of sphingolipids involved in membrane biogenesis. Rather, MAM CS seems to be in the "off" state before DSB-induced signaling, similar to the activation sequence during heat shock in Saccharomyces cerevisiae, where yeast CS activation is abrupt and requisite for completion of the heat shock adaptive response (43) . Furthermore, although currently it is technically infeasible to isolate MAM from C. elegans, the genetic and biochemical localization of CS-generated ceramide after radiation to mitochondria (11) suggests that MAM CS activation may serve as a generic source for registering stress at mitochondrial membranes.
The current data are consistent with two different models by which unrepaired or misrepaired DSBs might activate CS. In the most parsimonious, HR and NHEJ pathways normally mediate DSB repair, reducing the DSB load to below a threshold for CS signaling. Repair system insufficiency would yield persistent DSB levels sufficient for CS activation. Alternatively, a dynamic balance may exist between CS-activating and CS-attenuating signaling pathways, regulated by activation status of the DNA damage sensing and repair pathways. In wild-type intestines exposed to doses ≤16 Gy, the attenuating function would prevail, preventing crypt SCC apoptosis while DSBs are being repaired, whereas at higher doses the balance would shift to favor CS activation, enabling apoptosis. Irrespective of the mechanism used by DNA sensing and repair enzymes to regulate CS, which will require extensive future investigation to sort out, the present studies define robust and standardized in vivo readout systems for examination of allele-specific regulation of the DNA damage response. Evaluation of radioprotection or radiation sensitization of the intestines should be multiparametric, involving at a minimum the 3.5-day microcolony assay, Kaplan-Meier dose survival analysis with autopsy evaluation of every experimental animal at the time of death, coupled to assessment of endothelial and SCC apoptosis and their respective ceramide-generating mechanisms.
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